Kazuwa Nakao Selected Research

Kazuwa Nakao Research Topics

Disease

38	Obesity 04/2022 - 01/2002
23	Heart Failure 01/2022 - 09/2000
21	Body Weight (Weight, Body) 01/2020 - 10/2002
20	Fibrosis (Cirrhosis) 01/2020 - 05/2002
19	Hypertension (High Blood Pressure) 12/2021 - 09/2000
19	Insulin Resistance 01/2017 - 01/2002
15	Cardiomegaly (Heart Hypertrophy) 01/2020 - 02/2003
15	Neoplasms (Cancer) 01/2016 - 11/2002
13	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2003
13	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 07/2002
13	Hypertrophy 12/2013 - 09/2000
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 06/2004
9	Osteoporosis 07/2009 - 03/2002
7	Diabetes Mellitus 10/2022 - 12/2004
7	Chronic Renal Insufficiency 05/2020 - 06/2009
7	Hyperglycemia 10/2014 - 09/2003
6	Achondroplasia 12/2017 - 12/2003
6	Proteinuria 01/2017 - 07/2002
6	Ischemia 10/2009 - 03/2003
6	Myocardial Infarction 09/2009 - 05/2003
5	Inflammation (Inflammations) 01/2020 - 05/2010
5	Dyslipidemias (Dyslipidemia) 06/2017 - 06/2004
5	Hyperphagia (Overeating) 01/2017 - 03/2006
5	Albuminuria 01/2017 - 10/2006
5	Sudden Death 01/2016 - 02/2008
5	Hyperaldosteronism (Conn Syndrome) 12/2014 - 03/2002
5	Adenoma (Adenomas) 12/2014 - 03/2002
5	Stroke (Strokes) 09/2008 - 01/2002
4	Hypercholesterolemia 01/2018 - 12/2003
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2014 - 06/2009
4	Non-alcoholic Fatty Liver Disease 05/2014 - 12/2010
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 11/2002
4	Fatty Liver 09/2013 - 06/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 06/2013 - 08/2002
4	Insulinoma 01/2013 - 11/2002
4	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 11/2012 - 05/2004
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2011 - 10/2008
4	Dwarfism 12/2009 - 03/2002
4	Weight Gain 12/2009 - 06/2005
4	Edema (Dropsy) 08/2007 - 03/2003
3	Cardiomyopathies (Cardiomyopathy) 01/2020 - 06/2009
3	Left Ventricular Dysfunction 01/2020 - 05/2002
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 09/2004
3	Glomerulonephritis 01/2017 - 05/2003
3	Sclerosis 01/2017 - 02/2008

Drug/Important Bio-Agent (IBA)

28	LeptinIBA 04/2022 - 01/2002
22	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022 - 09/2000
18	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2002
16	Natriuretic PeptidesIBA 01/2020 - 12/2001
16	Insulin (Novolin)FDA Link 11/2012 - 01/2002
14	Atrial Natriuretic Factor (ANF)IBA 01/2020 - 10/2003
14	AldosteroneIBA 01/2020 - 03/2002
14	Hormones (Hormone)IBA 11/2012 - 09/2000
12	Triglycerides (Triacylglycerol)IBA 12/2021 - 04/2003
11	GhrelinIBA 01/2014 - 09/2002
11	Angiotensin IIIBA 12/2013 - 12/2001
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
9	LipidsIBA 04/2022 - 05/2002
9	Antihypertensive Agents (Antihypertensives)IBA 01/2011 - 02/2008
9	candesartanIBA 01/2011 - 02/2008
8	Messenger RNA (mRNA)IBA 09/2015 - 05/2003
7	GlucocorticoidsIBA 08/2016 - 06/2004
7	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2013 - 02/2005
7	Amlodipine (Norvasc)FDA LinkGeneric 01/2013 - 02/2008
6	CreatinineIBA 01/2016 - 11/2002
6	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2014 - 03/2002
6	Peptides (Polypeptides)IBA 01/2014 - 10/2002
6	Biomarkers (Surrogate Marker)IBA 09/2013 - 01/2007
6	atrial natriuretic factor receptor AIBA 10/2009 - 02/2004
5	Lipocalin-2IBA 11/2017 - 02/2009
5	AlbuminsIBA 01/2017 - 03/2006
5	Type 1 Angiotensin ReceptorIBA 01/2016 - 08/2007
5	AdrenomedullinIBA 06/2013 - 12/2005
5	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 11/2010 - 01/2002
5	EnzymesIBA 04/2010 - 06/2004
5	Pioglitazone (Actos)FDA Link 12/2009 - 09/2003
5	Transforming Growth Factor beta (TGF-beta)IBA 12/2003 - 09/2000
4	Atorvastatin (Lipitor)FDA Link 05/2020 - 02/2007
4	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2020 - 03/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 05/2002
4	Connective Tissue Growth FactorIBA 01/2017 - 05/2002
4	ReninIBA 01/2016 - 03/2002
4	cilnidipineIBA 01/2016 - 01/2011
4	LipopolysaccharidesIBA 11/2015 - 12/2003
4	CollagenIBA 11/2015 - 06/2005
4	Streptozocin (Streptozotocin)FDA Link 10/2014 - 03/2003
4	Alanine Transaminase (SGPT)IBA 05/2014 - 12/2010
4	RE1-silencing transcription factorIBA 05/2013 - 12/2006
4	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2010 - 06/2005
4	Raloxifene Hydrochloride (Evista)FDA Link 03/2008 - 12/2007
4	Thyroid HormonesIBA 08/2007 - 03/2002
4	Fibronectins (Fibronectin)IBA 07/2002 - 09/2000
3	Blood Glucose (Blood Sugar)IBA 12/2021 - 08/2010
3	HDL CholesterolIBA 12/2021 - 01/2008
3	4-nitrophenylphosphorylcholine (NPPC)IBA 12/2017 - 11/2008
3	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 12/2017 - 01/2004
3	des-n-octanoyl ghrelinIBA 01/2017 - 11/2002
3	Pharmaceutical PreparationsIBA 10/2016 - 12/2006

Therapy/Procedure

25	Therapeutics 01/2020 - 04/2003
5	Transplantation 01/2013 - 04/2003